fluconazole
Selected indexed studies
- Candida albicans targets that potentially synergize with fluconazole. (Crit Rev Microbiol, 2021) [PMID:33587857]
- Fluconazole: pharmacokinetics and indications. (Arch Med Res, 1993) [PMID:8118162]
- Fluconazole: a new antifungal agent. (Clin Pharm, 1991) [PMID:2040125]
_Worker-drafted node — pending editorial review._
Connections
fluconazole is a side effect of
Sources
- Candida albicans targets that potentially synergize with fluconazole. (2021) pubmed
- Fluconazole: pharmacokinetics and indications. (1993) pubmed
- Fluconazole: a new antifungal agent. (1991) pubmed
- Fluconazole prophylaxis in high-risk neonates. (2010) pubmed
- Efficacy of fluconazole for the treatment of onychomycosis. (2009) pubmed
- Fluconazole for the management of invasive candidiasis: where do we stand after 15 years? (2006) pubmed
- Fluconazole: a new triazole antifungal agent. (1990) pubmed
- Fluconazole: a new triazole antifungal agent. (1991) pubmed
- Fluconazole dose recommendation in urinary tract infection. (2001) pubmed
- Fluconazole: optimized antifungal therapy based on pharmacokinetics. (2002) pubmed